Replimune (REPL) Times Interest Earned (2019 - 2025)
Replimune's (REPL) quarterly Times Interest Earned came in at -$49.02 in Q4 2025, down 7.67% year-on-year from -$53.1 in Q4 2024, and up 13.46% quarter-over-quarter from -$56.65 in Q3 2025.
Replimune (REPL) Times Interest Earned (2019 - 2025) Analysis & Trends
Replimune has disclosed Times Interest Earned across 7 years of filings, most recently posting -$49.02 for Q4 2025.
- Times Interest Earned for Q4 2025 came in at -$49.02, down 7.67% year-over-year; the trailing twelve-month figure through Dec 2025 was -$55.33 (down 31.48% YoY), and the FY2025 annual result was -$45.3, up 13.22% from the prior year.
- Times Interest Earned came in at -$49.02 for Q4 2025 at Replimune, up from -$56.65 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$40.23 in Q2 2024 to a low of -$22184.0 in Q1 2021.
- The 5-year median for Times Interest Earned is -$50.88 (2023), against an average of -$1631.6.
- Across the five-year window, Times Interest Earned sank 40040.68% in 2021 and jumped 38.7% in 2024, its largest moves.
- Replimune's Times Interest Earned stood at -$22184.0 in 2021, then soared by 99.8% to -$44.24 in 2022, then declined by 26.29% to -$55.87 in 2023, then rose by 18.51% to -$45.53 in 2024, then retreated by 7.67% to -$49.02 in 2025.
- The last three Times Interest Earned figures came in at -$49.02 (Q4 2025), -$56.65 (Q3 2025), and -$61.3 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -258.33 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 11.79 |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - | -49.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -49.02 |
| Sep 30, 2025 | -56.65 |
| Jun 30, 2025 | -61.30 |
| Mar 31, 2025 | -54.30 |
| Dec 31, 2024 | -45.53 |
| Sep 30, 2024 | -40.97 |
| Jun 30, 2024 | -40.23 |
| Mar 31, 2024 | -41.55 |
| Dec 31, 2023 | -55.87 |
| Sep 30, 2023 | -66.84 |
| Jun 30, 2023 | -49.91 |
| Mar 31, 2023 | -51.85 |
| Dec 31, 2022 | -44.24 |
| Mar 31, 2021 | -22,184.00 |
| Dec 31, 2020 | -82.09 |
| Sep 30, 2020 | -68.75 |
| Jun 30, 2020 | -62.79 |
| Mar 31, 2020 | 55.54 |
| Dec 31, 2019 | -19.98 |
| Sep 30, 2019 | -62.78 |